www.zfenglish.com - Last update 11:36

  • About Us
  • Subscribe
  • Contact Us
  • About cookies
  • Advertising
  • Login
ZF English
advanced search
  • Macroeconomics
  • Banks-Insurance
  • Capital Market
  • Social/Politics
  • Companies
  • www.zf.ro
  • Automotive
  • Real Estate
  • Energy
  • Retail&Consumer
  • Health
  • Technology &Telecoms
  • HR
  • Media

Results 26 - 50 from 184 for "iasi"

+ advanced search
  • Antibiotice Iasi Wants to Cross RON100M Profit Threshold in 2024

    03.25.2024

    Antibiotice Iasi, the biggest Romanian-held drug manufacturer, wants to reach RON104 million net profit in 2024, up 28% from 2023, in line with its income and expenses budget. more

  • Antibiotice Iasi Seeks To Pay Dividends Of RON31M From 2023 Profit

    03.14.2024

    Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) is summoning its shareholders to approve, among others, the distribution of RON31 million from the company's 2023 profit under the form of more

  • Antibiotice Iasi's Net Profit More Than Doubles YoY To RON80.7M In 2023

    02.28.2024

    Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with more

  • Iasi City Hall Buys 18 Trams from Turkey’s Bozankaya in RON141M Contract

    02.20.2024

    Bozankaya, a Turkish-held public transport vehicle producer, has gained a project within a tender organized by Iasi City Hall via which it will deliver the municipality 18 trams with a length of more

  • Antibiotice Iasi Launches New Vet Product Range

    02.09.2024

    Antibiotice Iasi, the largest Romanian-held pharma producer, is launching eight veterinary products in the range of nutritional supplements, complementing the company’s veterinary prescription more

  • Antibiotice Iasi Calls Shareholders To Approve Contracting RON35M Credit Facility From Banca Transilvania

    01.25.2024

    The Board of Directors of pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) announced in a stock market report on Thursday (Jan. 25, 2024) that it has called shareholders for a meeting on February more

  • Perfumery Brand Obsentum Opens First Store In NE Romania, In Iasi

    12.19.2023

    Perfumery brand Obsentum has opened its first store in northeastern Romania in Iasi, in the Palas shopping center, and has reached a network of nine niche perfumeries in the country. more

  • Kiddo Group Opens Hype Energize Centre in Palas Iasi

    12.11.2023

    Kiddo group, specializing in the development of play centers for kids and young people owned by Vlad Alexandru and Cristina Sucu, has opened a Hype Energize-branded center in Palas Iasi, with this more

  • ELI Parks Set to Launch New Development Project in Iasi

    12.06.2023

    ELI Parks, one of the most dynamic developers on Romania’s logistic and industrial market, wants to start a new development project, ELI Park Iasi, a logistic and industrial park with a total more

  • Romania Property Club: City Of Iasi To Attract Private Real Estate Investments Of EUR500M In Coming Years

    11.27.2023

    Romania's eastern city of Iasi will be attracting private real estate investments of EUR500 million in the coming years, which will add to public infrastructure projects worth EUR1.2 billion announced more

  • Antibiotice Iasi Shares To Be Included In MSCI Indices Starting With 1st Trading Day Of Dec 2023

    11.16.2023

    The Bucharest Stock Exchange has announced Wednesday evening that the shares of Antibiotice (ATB.RO), the Romanian manufacturer of generic drugs, listed on the local capital market for 26 years, will more

  • Antibiotice Iasi Ends 9M 2023 with RON463.4M Turnover, Up 28%, RON76M Net Profit, More than Double the 9M 2022 Level

    11.15.2023

    Romanian state-owned pharma producer Antibiotice Iasi for the first nine months of 2023 reported RON463.4 million turnover, up 28%, and RON76 million net profit, more than doubled the RON30 million more

  • Antibiotice Iasi Shareholders OK EUR25M Funding from EIB

    10.31.2023

    The extraordinary general meeting of shareholders convened by drug maker Antibiotice Iasi on October 30 approved the signing of a financing contract worth EUR25 million euro, i.e. RON23 million more

  • Antibiotice Iasi Looks at New Export Markets

    10.05.2023

    Antibiotic Iasi, the biggest Romanian-held drug producer, is mulling new export markets, including Nordic ones, where it is trying to already develop its first local partnerships. more

  • IKEA's Fourth Store In Romania To Be Built In North-Eastern City Of Iasi

    10.04.2023

    IKEA Romania, one of the largest furniture and home décor retailers, part of Swedish IKEA Group, is set to build its fourth store in Romania, in the north-eastern city of Iasi, within the future more

  • Antibiotice Iasi Calls Shareholders To Approve EUR25M Financing Contract With The Romanian State

    09.16.2023

    Romanian state-owned pharmaceutical manufacturer Antibiotice (ATB.RO) has called shareholders for a general meeting on October 30, 2023 to secure approval for the conclusion of a financing contract more

  • Romanian Realty Developer Impact Gets Building Permit for Iasi Greenfield Copou

    07.21.2023

    Real estate developer Impact Developer&Contractor announced it got the construction authorization for Greenfield Copou residential project of Iasi, where it is set to develop 1062 apartments in 26 more

  • Regional Airports Drive Growth In Passenger Traffic In 2023

    07.19.2023

    Passenger traffic on Romania’s airports was higher in the first half of 2023 than in the same period of 2019. Contrary to expectations, however, the growth drivers were the regional airports and not more

  • IULIUS Group Set To Continue Development Of Palas Iasi Project With 8th Class A Office Building

    05.24.2023

    IULIUS Group plans to start in 2024 the construction of the eighth office building within the Palas Iasi project. more

  • SIF Oltenia Buys 2.4% Of Antibiotice Iasi Shares In RON9.3M Deal

    05.18.2023

    Antibiotice Iasi (ATB.RO), Romania’s most important generic drug manufacturer, on Thursday (May 18) informed the Bucharest Stock Exchange (BVB) that SIF Oltenia (SIF5.RO), its second largest more

  • Antibiotice Iasi Posts RON178M Sales in 1Q/2023, Up around 40%, Sees Net Profit Almost Triple To RON22M

    05.12.2023

    Romanian pharma producer Antibiotice Iasi ended the first quarter of 203 with RON178 million sales, up around 40%, and RON22 million net profit, almost triple the level of the year-earlier period. more

  • IULIUS Opens Palas Campus Iasi In EUR120M Investment

    04.26.2023

    IULIUS has officially opened Palas Campus, its second major urban regeneration project in Romania's north-eastern city of Iasi. more

  • Iulius Group Partners Up With MedCity To Open Medical Center Within Palas Campus Iasi Office Complex

    04.05.2023

    Iulius Group, a real estate developer held by businessman Iulian Dascalu, has concluded a partnership with MedCity for the setup of a medical center within the Palas Campus Iasi office complex. more

  • Continental Inaugurates EUR8M Testing Facility in Iasi

    04.03.2023

    German-held supplier of automotive components and systems and the largest manufacturer of automotive components in Romania Continental has expanded its center in Iasi with new test labs, following more

  • Fashion Brand Hugo Boss Opens Fourth Store in Romania in Palas Mall of Iasi

    03.16.2023

    German luxury brand Hugo Boss will open its first mall outside Bucharest and its fourth in Romania in Palas Iasi Mall. more

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • »
  • Macroeconomics
  • Banks-Insurance
  • Capital Market
  • Social/Politics
  • Companies
  • www.zf.ro
  • Automotive
  • Real Estate
  • Energy
  • Retail&Consumer
  • Health
  • Technology &Telecoms
  • HR
  • Media